Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 450 of 659 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/16
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 11/01/20
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 09/30/05
Due: 09/30/06
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 12/30/25
Due: 12/30/26
Phase: N/A
Priority: Normal
Start: 11/30/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 09/27/24
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 03/29/25
Due: 03/29/26
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 05/31/23
Due: 05/31/24
Phase: N/A
Priority: Normal
Start: 09/15/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 01/26/18
End: 08/15/28
Due: 08/15/29
FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: -
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 02/01/20
End: 12/20/22
Due: 12/20/23
Phase: N/A
Priority: Normal
Start: 03/21/21
End: 11/01/22
Due: 11/01/23
Phase: N/A
Priority: Normal
Start: 01/01/25
End: 01/01/27
Due: 01/01/28
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 03/10/21
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 01/31/19
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 04/01/19
Due: 04/01/20
Phase: N/A
Priority: Normal
Start: 01/17/19
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 05/31/03
End: 12/31/09
Due: 12/31/10